Age Related Macular Degeneration News and Research

RSS

AAO urges people to protect themselves from age-related macular degeneration

Even though Marlene Klein was having trouble recognizing familiar faces and began to mistake her fingers for carrots as she chopped vegetables, she had no idea she was slowly losing her vision to a leading cause of blindness, age-related macular degeneration.

14 Feb 2020

Discovery of potential cause of age-related macular degeneration

Age related macular degeneration or AMD leads to loss of vision in around 1.5 million people in the United Kingdom and millions of others around the world. In a new study researchers have discovered a new protein that could explain the causation and thus provide clues to its early diagnosis and effective treatment. The study was published in the latest issue of the journal Nature Communications.

9 Feb 2020

Researchers offer new hope for diagnosis, treatment of age-related macular degeneration

Researchers have identified a new protein linked to age-related macular degeneration (AMD) that could offer new hope for the diagnosis and treatment of the disease, which affects over 1.5 million people in the UK alone.

8 Feb 2020

Missing doctor's visit linked to decreased visual acuity for patients with AMD

Missing a single ophthalmology appointment over a two-year period was associated with decreased visual acuity for patients with macular degeneration -- a leading cause of permanent vision loss in the elderly -- according to a new Penn Medicine study.

6 Feb 2020

Researchers identify potential way to halt age-related macular degeneration

Researchers have successfully treated age-related macular degeneration in mice after finding an unexpected link between the two main forms of the blinding eye disease, the leading cause of vision loss in people 60 and older.

22 Jan 2020

Fight for Sight funds research to investigate genetic risk of age-related macular degeneration

Eye research charity Fight for Sight is funding researchers from the University of Manchester to investigate the genetic risk of the UK’s leading cause of blindness, age-related macular degeneration.

20 Jan 2020

Older people can improve their vision by changing the power of glasses

Overall, Swedish 70-year-olds' eyesight is good, but many could see even better. Six in ten can improve their vision by getting eyeglasses or changing the power of the glasses they already have, according to a new study from the University of Gothenburg.

14 Jan 2020

UPMC implants first patient in the U.S. with new wireless retinal device

UPMC has implanted the first patient in the United States with a new wireless retinal device as part of a clinical trial aimed at restoring partial sight to patients with advanced age-related macular degeneration, a disease that leads to permanent blindness.

13 Jan 2020

Survey uncovers key gaps in American's knowledge of eye health

A survey conducted by The Harris Poll has uncovered key gaps in American's knowledge of eye health, and what they don't know is putting them at risk of vision loss.

13 Jan 2020

Study shows how diet plays a role in age-related macular degeneration

Participants who ate a diet high in red and processed meat, fried food, refined grains and high-fat dairy were three times more likely to develop an eye condition that damages the retina and affects a person's central vision, according to the results of a study from the University at Buffalo.

11 Dec 2019

Newly developed cell models can open up new avenues for ocular drug discovery

Researchers at the University of Eastern Finland have developed two new cell models that can open up new avenues for ocular drug discovery. The new cell models are continuously growing retinal pigment epithelial cells, which have many benefits over the models currently used by researchers and pharmaceutical companies. The models were developed by Professor Arto Urtti's Ocular Drug Delivery group at the University of Eastern Finland.

4 Dec 2019

Thermally induced mixing technique could improve treatment of AMD

Age-related macular degeneration is the primary cause of central vision loss and results in the center of the visual field being blurred or fully blacked out. Though treatable, some methods can be ineffective or cause unwanted side effects.

23 Nov 2019

Study shows importance of targeted antibody treatment for patients with wet macular degeneration

Wet age-related macular degeneration is one of the leading causes of blindness in the U.S. Breakthrough treatments come with a steep price tag and treatment burden for the patient, but a new study suggests their benefits to patient health and society top billions of dollars, or more, if adherence could be improved.

15 Nov 2019

Age-related macular degeneration (AMD) may affect 77 million Europeans by 2050

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in adults who are more than 50. A new study revealed that the condition might affect 77 million Europeans come 2050.

12 Nov 2019

Genetic mutation of APOE gene may provide protection against Alzheimer's disease

A team of researchers has identified that a genetic mutation of the APOE gene, the major susceptibility gene for late-onset Alzheimer's disease, may provide protection against the devastating neurological illness.

4 Nov 2019

Study pinpoints cell types linked to age-related macular degeneration

Age-related macular degeneration is one of the leading causes of blindness in the elderly, affecting more than 2 million people in the United States and leading to progressive loss of central vision.

25 Oct 2019

Ophthalmologists find more evidence linking common bladder drug to retinal conditions

A drug widely prescribed for a bladder condition for decades, now appears to be toxic to the retina, the light sensing tissue at the back of the eye that allows us to see.

14 Oct 2019

New gene therapy for wet age-related macular degeneration is on the horizon

Gene therapy is showing promise for one of the most common causes of blindness. Data presented today shows that six patients with wet age-related macular degeneration have, so far, gone at least six months without the need for continued injections to control a disease that typically requires treatment every four to six weeks.

11 Oct 2019

Medical and surgical eye care experts gather in San Francisco for AAO 2019

More than 25,000 are expected to attend the American Academy of Ophthalmology's 123rd annual meeting, AAO 2019, from Oct. 12-15 at the Moscone Center in San Francisco.

11 Oct 2019

WHO’S first world report on vision

Vision is the most compelling contributor to the quality of our senses, and yet eye care lags behind many other areas in the importance it commands in public health. The World Health Organization (WHO) has said, in its report timed for World Sight Day (October 10), that over 2.2 billion people around the world (out of a total of 7.7 billion) are blind, completely or partially.

9 Oct 2019